PDS Biotechnology Corp. (PDSB)
1.06
+0.03
(+2.91%)
USD |
NASDAQ |
Jun 10, 16:00
1.03
-0.03
(-2.83%)
After-Hours: 06:04
PDS Biotechnology 1 Year Total Returns (Daily) : -36.90% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -36.90% |
| June 09, 2026 | -39.77% |
| June 08, 2026 | -40.83% |
| June 05, 2026 | -34.62% |
| June 04, 2026 | -26.06% |
| June 03, 2026 | -29.41% |
| June 02, 2026 | -17.73% |
| June 01, 2026 | -17.39% |
| May 29, 2026 | -22.86% |
| May 28, 2026 | -21.90% |
| May 27, 2026 | -22.38% |
| May 26, 2026 | -30.38% |
| May 22, 2026 | -23.57% |
| May 21, 2026 | -26.58% |
| May 20, 2026 | -36.81% |
| May 19, 2026 | -31.51% |
| May 18, 2026 | -16.90% |
| May 15, 2026 | -0.74% |
| May 14, 2026 | 9.16% |
| May 13, 2026 | 4.72% |
| May 12, 2026 | -14.73% |
| May 11, 2026 | 8.33% |
| May 08, 2026 | 2.46% |
| May 07, 2026 | -1.72% |
| May 06, 2026 | -10.92% |
| Date | Value |
|---|---|
| May 05, 2026 | -19.08% |
| May 04, 2026 | -27.54% |
| May 01, 2026 | -26.26% |
| April 30, 2026 | -30.50% |
| April 29, 2026 | -23.79% |
| April 28, 2026 | -12.90% |
| April 27, 2026 | -25.60% |
| April 24, 2026 | -31.78% |
| April 23, 2026 | -24.54% |
| April 22, 2026 | 12.17% |
| April 21, 2026 | 24.07% |
| April 20, 2026 | 19.44% |
| April 17, 2026 | 21.30% |
| April 16, 2026 | 23.08% |
| April 15, 2026 | 22.52% |
| April 14, 2026 | -1.85% |
| April 13, 2026 | 5.83% |
| April 10, 2026 | 12.11% |
| April 09, 2026 | 7.00% |
| April 08, 2026 | 5.87% |
| April 07, 2026 | -4.69% |
| April 06, 2026 | -17.86% |
| April 02, 2026 | -45.02% |
| April 01, 2026 | -43.86% |
| March 31, 2026 | -49.16% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Abeona Therapeutics, Inc. | -17.03% |
| ACADIA Pharmaceuticals, Inc. | -4.28% |
| Alnylam Pharmaceuticals, Inc. | -3.72% |
| Savara, Inc. | 118.5% |
| Vericel Corp. | -18.21% |